[Our experience in the treatment of the parkinsonian syndrome with L-dopa. I. Evaluation of the clinical results]

Riv Patol Nerv Ment. 1969 Oct;90(5):329-49.
[Article in Italian]
No abstract available

MeSH terms

  • Dihydroxyphenylalanine / therapeutic use*
  • Humans
  • Intracranial Arteriosclerosis / complications
  • Parkinson Disease / drug therapy*
  • Parkinson Disease, Postencephalitic / drug therapy*

Substances

  • Dihydroxyphenylalanine